 |
 |
Deanne Charlton wrote: > > In a message dated 97-05-20 07:56:58 EDT, Jim wrote to David: > > << Selegeline Hydrochloride (Eldepryl, et al) can delay Parkinsonian > disability and the need for levodopa therapy by 9-12 months if given in the > early stages. Later, in combination with levodopa, it can reduce levodopa > requirements by 20-50%, and reduce levodopa's side effects. It may have a > neuro-protective effect. One of the side-effects can be insomnia. >> > > For more on eldepryl, its side effects and a different form of it that seems > to have greater positive effects w/ fewer side effects, try www.ceri.com > for their information on PD. > > Deanne Charlton > [log in to unmask] Thanks for the not Deanne. Have a good weekend. Best wishes